Back to search
SAM.govRef 75A50126C00011

Advanced Development of OXOS X3, a Point-of-Care Diagnostic X-Ray Imaging System for Detection of Fracture and other Trauma

OOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE logo
Contracting officeOffice of Assistant Secretary for Preparedness and Response
ClosedServicesNAICS 541714
Submission deadlineSep 25, 202612:00 AM EDTClosed
PublishedSep 29, 2026
LocationAtlanta, GA
Notice type
Special Notice
Product or service code
AN13 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT
Set-aside
Not specified
Place of performance
GeorgiaAtlanta, GA
Official notice
View on SAM.gov ↗

Description

Transform trauma response by bringing hospital-grade imaging directly to the point of need by developing and receiving FDA clearance of the OXOS X3, an ultra-portable, high-output general radiography and fluoroscopy system engineered to function as a threatagnostic medical countermeasure (MCM). Designed to weigh under 25 pounds and deliver up to 100 kV / 15 mA at the point of need, X3 augments the transport-to-imaging bottleneck that currently degrades survival in mass casualty incidents (MCIs) involving nuclear detonation, conventional blast, or large-scale trauma surge events. By bringing hospital-grade diagnostic capability directly to the casualty, whether in a high-volume Emergency Department, a temporary field hospital, or a triage site, X3 restores the diagnostic foundation of the ATLS primary survey at every step where current portable assets fail.

The rest of this notice

The buyer's named contact and the award details for this notice are free. Create an account to open the full record.

  • Contact the buyer directly
  • See who won, and for how much
  • Get alerts for opportunities like this one
Create a free account

Free — no card, no trial clock.

Get new Research and Development in Biotechnology (except Nanobiotechnology) contracts by email — free, no card needed.
Create a free alert